Tag Archives: SAVA

Cassava Sciences Inc (SAVA) Receives a Buy from H.C. Wainwright

In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Cassava Sciences Inc (SAVA – Research Report), with a price target of $3. The company’s shares closed last Monday at $1.19. Bernardino commented: “Our $3

Analysts’ Top Healthcare Picks: Cassava Sciences Inc (SAVA), Logicbio Therapeutics Inc (LOGC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cassava Sciences Inc (SAVA – Research Report) and Logicbio Therapeutics Inc (LOGC – Research Report) with bullish sentiments. Cassava Sciences Inc (SAVA)

Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences Inc (SAVA), Amag Pharmaceuticals (AMAG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cassava Sciences Inc (SAVA – Research Report) and Amag Pharmaceuticals (AMAG – Research Report) with bullish sentiments. Cassava Sciences Inc (SAVA) Cassava